Not yet recruiting
Permian Health Women's Lung Health Study
NCT06029543
- Conditions
- Alpha 1-Antitrypsin, COPD, Chronic Disease, +17 more
- Locations
-
- Gamcotrap Kanifing, The Gambia
Clinical trial condition
Subcutaneous Emphysema
Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.
97 public trials
16 recruiting studies
Subcutaneous Emphysema trial results
Enrolling by invitation
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
NCT02796937
- Conditions
- Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +14 more
- Locations
-
- Grifols Investigative Site Phoenix, Arizona, United States
- Grifols Investigative Site Miami, Florida, United States
- Grifols Investigative Site Wilmington, North Carolina, United States
- Grifols Investigative Site Portland, Oregon, United States
Enrolling by invitation
Alpha-1 Foundation DNA and Tissue Bank
NCT00884455
- Conditions
- Alpha 1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
- Locations
-
- University of Florida Gainesville, Florida, United States
Enrolling by invitation
Preparation of IPSC for Cell Gene Editing for the Treatment of AATD
NCT06892236
- Conditions
- Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
- Locations
-
- Fondazione IRCCS Policlinico San Matteo, Sc Pneumologia Pavia, Italy
Active, not recruiting
Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
NCT01983241
- Conditions
- Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +14 more
- Locations
-
- Grifols Investigative Site Phoenix, Arizona, United States
- Grifols Investigative Site Gainesville, Florida, United States
- Grifols Investigative Site Leesburg, Florida, United States
- Grifols Investigative Site Miami, Florida, United States
Active, not recruiting
Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants
NCT06738017
- Conditions
- Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
- Locations
-
- University of California, San Diego San Diego, California, United States
- Saint Louis University St Louis, Missouri, United States
- Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States
- The Medical University of South Carolina Charleston, South Carolina, United States
Active, not recruiting
Alpha-1 Antitrypsin Deficiency Adult Liver Study
NCT02014415
- Conditions
- Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +10 more
- Locations
-
- University of California San Diego, California, United States
- Boston University School of Medicine Boston, Massachusetts, United States
- Saint Louis University St Louis, Missouri, United States
Active, not recruiting
A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD
NCT06405633
- Conditions
- Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
- Locations
-
- St. Vincent's Hospital, Melbourne Fitzroy, Victoria, Australia
- Dalhousie University - Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
- Inspiration Research Limited Toronto, Ontario, Canada
- Turku University Hospital Turku, Finland
Active, not recruiting
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
NCT05897424
- Conditions
- Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
- Locations
-
- UAB Lung Health Center- Site Number : 105 Birmingham, Alabama, United States
- St Joseph's Hospital and Medical Center- Site Number : 126 Phoenix, Arizona, United States
- David Geffen School of Medicine at UCLA- Site Number : 124 Los Angeles, California, United States
- University of California Davis Medical Center- Site Number : 110 Sacramento, California, United States
Active, not recruiting
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
NCT05297812
- Conditions
- Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +10 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California - Los Angeles Los Angeles, California, United States
- National Jewish Health Denver, Colorado, United States
- University of Chicago Chicago, Illinois, United States